Curis (CRIS)

• Market cap: $15M
• 1 day: 2.59%
• 5 days: -13.14%
• 1 month: -3.25%
• 3 months: -30%
• 6 months: -51.82%
• Year to date: -71.93%
• 1 year: -65.8%
• 5 years: -99.26%
• 10 years: -99.59%
• Sector: Healthcare
• Industry: Biotechnology

About: Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Employees: 33